Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionIMA Wealth, Inc.
Latest Disclosed Ownership566 shares
Latest Disclosed Value $ 78,883
IMA Wealth, Inc. ownership in GILD / Gilead Sciences, Inc.

On May 6, 2026 - IMA Wealth, Inc. filed a 13F-HR form disclosing ownership of 566 shares of Gilead Sciences, Inc. (CH:GILD) valued at $78,883 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 566 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Gilead Sciences Common Stock 375558103 566 0 0.00 79 13.04 0.0077
2026-02-11 2025-12-31 13F Gilead Sciences Common Stock 375558103 566 64 12.75 69 25.45 0.0067
2025-11-06 2025-09-30 13F Gilead Sciences Common Stock 375558103 502 144 40.22 56 41.03 0.0056
2025-08-08 2025-06-30 13F Gilead Sciences Common Stock 375558103 358 9 2.58 40 0.00 0.0043
2025-05-06 2025-03-31 13F Gilead Sciences Common Stock 375558103 349 349 39 0.0046
2025-02-14 2024-12-31 13F Gilead Sciences Common Stock 375558103 0 -104 -100.00 0 -100.00
2024-11-14 2024-09-30 13F Gilead Sciences Common Stock 375558103 104 104 9 0.0019
2023-08-15 2023-06-30 13F GILEAD SCIENCES COM 375558103 0 -36 -100.00 0 -100.00
2023-05-16 2023-03-31 13F GILEAD SCIENCES COM 375558103 36 0 0.00 3 -33.33 0.0008
2023-02-16 2022-12-31 13F GILEAD SCIENCES COM 375558103 36 0 0.00 3 50.00 0.0008
2022-11-15 2022-09-30 13F GILEAD SCIENCES COM 375558103 36 0 0.00 2 0.00 0.0005
2022-08-18 2022-06-30 13F GILEAD SCIENCES COM 375558103 36 0 0.00 2 0.00 0.0005
2022-06-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 36 0 0.00 2 -33.33 0.0005
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 36 0 0.00 3 0.00 0.0007
2021-11-03 2021-09-30 13F GILEAD SCIENCES COM 375558103 36 0 0.00 3 50.00 0.0007
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 36 0 0.00 2 0.00 0.0005
2021-05-13 2021-03-31 13F GILEAD SCIENCES COM 375558103 36 -163 -81.91 2 -83.33 0.0005
2021-02-08 2020-12-31 13F GILEAD SCIENCES COM 375558103 199 -40,341 -99.51 12 -99.53 0.0034
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 40,540 -1,636 -3.88 2,562 -21.05 0.8590
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 42,176 -13,100 -23.70 3,245 -21.47 1.1733
2020-04-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 55,276 11,560 26.44 4,132 45.44 1.8185
2020-02-24 2019-12-31 13F GILEAD SCIENCES COM 375558103 43,716 13,456 44.47 2,841 48.12 1.0544
2019-10-29 2019-09-30 13F GILEAD SCIENCES COM 375558103 30,260 578 1.95 1,918 -4.34 0.7244
2019-07-19 2019-06-30 13F GILEAD SCIENCES COM 375558103 29,682 984 3.43 2,005 7.45 0.7496
2019-05-09 2019-03-31 13F GILEAD SCIENCES COM 375558103 28,698 21,577 303.01 1,866 319.33 0.7244
2019-01-15 2018-12-31 13F GILEAD SCIENCES COM 375558103 7,121 1,710 31.60 445 6.46 0.2076
2018-10-18 2018-09-30 13F GILEAD SCIENCES COM 375558103 5,411 314 6.16 418 15.79 0.1635
2018-08-01 2018-06-30 13F GILEAD SCIENCES COM 375558103 5,097 -206 -3.88 361 -9.75 0.1504
2018-04-20 2018-03-31 13F GILEAD SCIENCES COM 375558103 5,303 0 0.00 400 5.26 0.1780
2018-02-05 2017-12-31 13F GILEAD SCIENCES COM 375558103 5,303 -3,667 -40.88 380 -47.73 0.1700
2017-10-24 2017-09-30 13F GILEAD SCIENCES COM 375558103 8,970 -295 -3.18 727 10.82 0.3373
2017-07-31 2017-06-30 13F GILEAD SCIENCES COM 375558103 9,265 -260 -2.73 656 1.39 0.3155
2017-06-06 2017-03-31 13F GILEAD SCIENCES COM 375558103 9,525 338 3.68 647 -1.67 0.3256
2017-03-30 2016-12-31 13F Gilead Sciences COM 375558103 9,187 3,571 63.59 658 48.20 0.4054
2016-12-07 2016-09-30 13F Gilead Sciences COM 375558103 5,616 5,616 0.00 444 0.2538
2016-12-08 2016-03-31 13F Gilead Sciences COM 375558103 0 0 0 0.0000
2016-12-08 2015-09-30 13F Gilead Sciences COM 375558103 0 -3,040 -100.00 0 -100.00
2015-07-24 2015-06-30 13F Gilead Sciences COM 375558103 3,040 970 46.86 356 75.37 0.1693
2015-04-14 2015-03-31 13F Gilead Sciences COM 375558103 2,070 2,070 203 0.0987
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.